Company profile
Inhibrx company profile
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology, orphan diseases, and infectious diseases. Inhibrx has collaborations with Celgene and Bluebird Bio and has received awards from several granting agencies, including NIH, NIAID, and CARB-X.
Business identity
- Website
- http://inhibrx.com
- Phone number
- (858) 795-4220
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $10M-$100M
- Founded
- 2010-01-01, Year
Headquarters
- Headquarters
- San Diego, California, United States
- Postal code
- 92037
- Country code
- US
- Continent
- North America